Company Quick10K Filing
GB Sciences
10-Q 2020-12-31 Filed 2021-02-16
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-09-02
10-K 2020-03-31 Filed 2020-08-28
10-Q 2019-12-31 Filed 2020-02-18
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-15
S-1 2019-05-03 Public Filing
10-K 2019-03-31 Filed 2019-07-15
S-1 2019-03-12 Public Filing
10-Q 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-09-20 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-29
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-07-12
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-07-14
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-18
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-10-01 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-19
10-K 2013-03-31 Filed 2013-07-15
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-12-13
10-Q 2012-06-30 Filed 2012-08-20
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-22
10-K 2011-03-31 Filed 2011-07-11
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-22
8-K 2020-12-16 Leave Agreement, M&A
8-K 2020-11-23
8-K 2020-11-20
8-K 2020-10-15
8-K 2020-10-14
8-K 2020-10-14
8-K 2020-08-18
8-K 2020-06-29
8-K 2020-05-12
8-K 2020-04-23
8-K 2020-04-09
8-K 2020-03-24
8-K 2019-11-27
8-K 2019-11-19
8-K 2019-11-07
8-K 2019-10-23
8-K 2019-09-12
8-K 2019-09-01
8-K 2019-08-15
8-K 2019-08-10
8-K 2019-07-26
8-K 2019-06-17
8-K 2018-09-21
8-K 2018-09-21
8-K 2018-04-06
8-K 2018-03-07
8-K 2018-02-23

GB Sciences Financials

GBLX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash90018003,2131,6382820345671782,0729911,4559711,4873,5804,65932422885
Accounts Receivable150501069686868248553667907430488187
Inventory32735336071,0491,4132,8332,1371,542
PP&E3636363600781456999831,5871,8953,2286,8257,6848,60511,29611,73215,22316,25023,11925,86810,265
Assets6349424225533,3122,0131,5861,4512,2842,3373,5609,3239,12311,85515,16016,39724,05028,26230,63530,02329,840
Accounts Payable0423111134212446771,0961,1517631481264576933722982,2703,0711,621
Long-Term Debt2,0202,0954731355314225521521
Liabilities1,7311,7519648741,2569631,144616-55411,2052,8413,5804,2237,2405,4824,4307,4957,9218,4188,37411,26412,86715,525
Stockholders' Equity-1,669-1,702-922-832-1,232-958-1,1412,6962,0181,148246-557-1,244-6162,0733,5847,3167,5358,47612,74913,38910,3308,3005,288
Income Statement ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Revenue00000000000000541371,2758751,3156967261,172
Cost of Revenue0000000003882255813032,0601,857
Gross Profit000000000887650735393-1,334-685
R&D
SG&A221818614135621,780678-11,9272,6931,1291,2082,1983,2152,8752,7797,1076,7754,4642,9833,7871,403
Tax738-211-57
Net Income-75-34-3190274-183-1,445-1,670-622-3,986-2,681-1,097-1,341-2,467-3,524-3,082-3,145-6,962-9,779-5,167-3,763-4,983-2,683
Cash Flow ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash Operating-9-11-5-939-1,507-869-231-958-735-1,148-2,190-3,061-2,771-4,225-3,496-1,708
Cash Investing000-29-69-557-8-892-87-1,024-138-510-829-3,927-2,662-1,138
Cash Financing01153,842071-441,9942,7161,0911,0903,0884,11610,2457,2372,749